The US FDA has issued a statement on the use of conjugated estrogens/medroxyprogesterone

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1359, 2002-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Following a review of four published observational studies, the US FDA has issued a statement

Reactions Weekly, Vol. 1, Iss. 1335, 2011-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The US FDA has issued a nationwide alert warning consumers not to use Liqiang 4 Dietary Supplement Capsules

Inpharma, Vol. 1, Iss. 1495, 2005-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Tiratricol warning issued by US FDA

Inpharma, Vol. 1, Iss. 1266, 2000-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

The US FDA has issued a Talk Paper advising of changes to the US Strattera [atomoxetine] labelling

Reactions Weekly, Vol. 1, Iss. 1033, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

A consensus statement on the use of IV immunoglobulins in patients with autoimmune mucocutaneous blister diseases has been issued

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 430, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite